Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group.

Intern Med · 2021 · PMC8355380 · PMID 33612681

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

marginal significancep=0.052so close (0.05 < p ≤ 0.1)

The difference in the frequency of a history of CVD between the 2 groups showed marginal significance (21.0% in the CVD group vs. 7.6% in the non-CVD groups, p=0.052).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.